Substituted tetracycline compounds for treatment of inflammatory skin disorders
Inventors
Assefa, Haregewein • Bhatia, Beena • DRAPER, MICHAEL P. • Honeyman, Laura • Kim, Oak • Molnar, Dennis P.
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
Methods and compositions for the treatment of skin disorders (e.g., acne, rosacea) are described.
Core Innovation
The invention provides methods for treating a subject suffering from an inflammatory skin disorder by administering an effective amount of a substituted tetracycline compound of formula I, or a pharmaceutically acceptable salt thereof. The disclosure identifies pharmaceutical compositions comprising substituted tetracyclines of formulas I–VI, including 9-aminoalkyl, heteroaryl, cyano/amino, and cyclobutenedione-substituted derivatives. These compositions are formulated for topical, oral, or parenteral administration, either alone or in combination with a second agent.
The targeted inflammatory skin disorders include acne and rosacea. The substituted tetracycline compounds exhibit narrow-spectrum antibacterial activity against gram-positive organisms alongside anti-inflammatory activity, including reduction of carrageenan-induced paw inflammation. Furthermore, the compounds demonstrate potential for reduced phototoxicity relative to doxycycline and exhibit greater oxidative stability or lower oxidative potential than minocycline.
Claims Coverage
The claims identify one independent claim directed to treating an inflammatory skin disorder, comprising two inventive features.
Treatment of an inflammatory skin disorder
Administering an effective amount of a substituted tetracycline compound to a subject suffering from an inflammatory skin disorder, such that the disorder is treated.
Substituted tetracycline compound of formula I
The administered substituted tetracycline compound is a compound of formula I, or a pharmaceutically acceptable salt thereof, with substituents defined in the claim.
The claim covers administering an effective amount of a defined substituted tetracycline compound of formula I or a pharmaceutically acceptable salt thereof to treat an inflammatory skin disorder.
Stated Advantages
The compounds exhibit narrow-spectrum antibacterial activity against gram-positive bacteria and demonstrate anti-inflammatory activity, with compounds A and P reducing carrageenan-induced paw inflammation compared with controls.
The compounds demonstrate potential for reduced phototoxicity relative to doxycycline.
The compounds demonstrate greater oxidative stability or lower oxidative potential than minocycline.
Documented Applications
Treatment of inflammatory skin disorders, including acne and rosacea, using substituted tetracycline compounds or their pharmaceutically acceptable salts.
Topical, oral, or parenteral administration of substituted tetracycline compounds, administered alone or in combination with a second agent.
Pharmaceutical compositions comprising substituted tetracyclines, optionally administered with a second agent, for treating inflammatory skin disorders.
Interested in licensing this patent?